Gene · 762
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases. | J Enzyme Inhib Med Chem | 2022 | 34894971 | PubTator, text mining | PubMed |
| Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective. | Drug Discov Today | 2022 | 34890803 | PubTator, text mining | PubMed |
| Transcriptomic taxonomy and neurogenic trajectories of adult human, macaque, and pig hippocampal and entorhinal cells. | Neuron | 2022 | 34798047 | PubTator, text mining | PubMed |
| Seizure control does not predict hippocampal subfield volume change in children with focal drug-resistant epilepsy. | Neuroradiol J | 2022 | 34618625 | PubTator, text mining | PubMed |
| Chemical Synthesis and Semisynthesis of Lipidated Proteins. | Angew Chem Int Ed Engl | 2022 | 34611966 | PubTator, text mining | PubMed |
| Clinical Application of MPRAGE Wave Controlled Aliasing in Parallel Imaging (Wave-CAIPI): A Comparative Study with MPRAGE GRAPPA. | Magn Reson Med Sci | 2022 | 34602534 | PubTator, text mining | PubMed |
| COVID19db: a comprehensive database platform to discover potential drugs and targets of COVID-19 at whole transcriptomic scale. | Nucleic Acids Res | 2022 | 34554255 | PubTator, text mining | PubMed |
| Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand? | Br J Ophthalmol | 2022 | 34433550 | PubTator, text mining | PubMed |
| Engineered protein-small molecule conjugates empower selective enzyme inhibition. | Cell Chem Biol | 2022 | 34363759 | PubTator, text mining | PubMed |
| Study on potential differentially expressed genes in stroke by bioinformatics analysis. | Neurol Sci | 2022 | 34313877 | PubTator, text mining | PubMed |
| Computational modeling predicts potential effects of the herbal infusion "horchata" against COVID-19. | Food Chem | 2022 | 34311241 | PubTator, text mining | PubMed |
| Neutralizing anti-IL-1 receptor antagonist autoantibodies induce inflammatory and fibrotic mediators in IgG4-related disease. | J Allergy Clin Immunol | 2022 | 33974929 | PubTator, text mining | PubMed |
| In vivo hippocampal subfield volumes in bipolar disorder-A mega-analysis from The Enhancing Neuro Imaging Genetics through Meta-Analysis Bipolar Disorder Working Group. | Hum Brain Mapp | 2022 | 33073925 | PubTator, text mining | PubMed |
| Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma. | J Liver Cancer | 2021 | 37384270 | PubTator, text mining | PubMed |
| Nanoparticles and bioorthogonal chemistry joining forces for improved biomedical applications. | Nanoscale Adv | 2021 | 36132873 | PubTator, text mining | PubMed |
| A network pharmacology study on main chemical compounds from Hibiscus cannabinus L. leaves. | RSC Adv | 2021 | 35423640 | PubTator, text mining | PubMed |
| CA9-Related Acidic Microenvironment Mediates CD8+ T Cell Related Immunosuppression in Pancreatic Cancer. | Front Oncol | 2021 | 35155218 | PubTator, text mining | PubMed |
| Development of a Novel Anti-CD19 CAR Containing a Fully Human scFv and Three Costimulatory Domains. | Front Oncol | 2021 | 35117999 | PubTator, text mining | PubMed |
| Advances in the analysis of single extracellular vesicles: A critical review. | Sens Actuators Rep | 2021 | 35098157 | PubTator, text mining | PubMed |
| Developing a Rational, Optimized Product of Centella asiatica for Examination in Clinical Trials: Real World Challenges. | Front Nutr | 2021 | 35096945 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/762/papers?page=30